Active, Not Recruiting
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
NCT03907852
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +38 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- University of Miami Sylvester Cancer Center Miami, Florida, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- National Cancer Institute Bethesda, Maryland, United States